Literature DB >> 23479023

Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state.

E V Usova1, M R Kopantseva, M B Kostina, A N Van'kovich, V I Egorov, E P Kopantsev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23479023     DOI： 10.1134/S001249661301016X

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  13 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Calreticulin represses E-cadherin gene expression in Madin-Darby canine kidney cells via Slug.

Authors:  Yasushi Hayashida; Yoshishige Urata; Eiji Muroi; Takaaki Kono; Yasuyoshi Miyata; Koichiro Nomata; Hiroshi Kanetake; Takahito Kondo; Yoshito Ihara
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

3.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

4.  Secreted growth factors from stromal fibroblasts of the human lung and pancreatic carcinomas.

Authors:  E P Kopantzev; O V Melekhina; M R Kopantseva; V V Mochal'nikova; T V Vinogradova; V I Egorov; I B Zborovskaia; A V Fedorov; E D Sverdlov
Journal:  Dokl Biol Sci       Date:  2009 Nov-Dec

Review 5.  Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.

Authors:  S Floor; W C G van Staveren; D Larsimont; J E Dumont; C Maenhaut
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

6.  Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.

Authors:  Kashelle Lockman; Jeremiah S Hinson; Matt D Medlin; Dionne Morris; Joan M Taylor; Christopher P Mack
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma.

Authors:  Eugene P Kopantzev; Galina S Monastyrskaya; Tatyana V Vinogradova; Marina V Zinovyeva; Marya B Kostina; Olga B Filyukova; Alexander G Tonevitsky; Gennady T Sukhikh; Eugene D Sverdlov
Journal:  Lung Cancer       Date:  2008-04-03       Impact factor: 5.705

10.  Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.

Authors:  Jakob Mejlvang; Marina Kriajevska; Cindy Vandewalle; Tatyana Chernova; A Emre Sayan; Geert Berx; J Kilian Mellon; Eugene Tulchinsky
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138
View more
  5 in total

1.  microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.

Authors:  Anusha Sathyanarayanan; Karthik Subramanian Chandrasekaran; Devarajan Karunagaran
Journal:  Cell Oncol (Dordr)       Date:  2016-12-08       Impact factor: 6.730

2.  Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.

Authors:  Wei Li; Xionghui Hu; Xiaolin Huang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer.

Authors:  Yan Hou; Junwen Zhen; Xiaodong Xu; Kun Zhen; Bin Zhu; Rui Pan; Chidong Zhao
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

4.  MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.

Authors:  Chao Zu; Shizhang Liu; Wei Cao; Zongzhi Liu; Hui Qiang; Yong Li; Chong Cheng; Le Ji; Jianhui Li; Jingyuan Li
Journal:  Oncotarget       Date:  2017-05-23

5.  MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.

Authors:  Jiacong You; Yang Li; Nianzhen Fang; Bin Liu; Lingling Zu; Rui Chang; Xuebing Li; Qinghua Zhou
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.